Cite

    Shovman, O., Gilburd, B., Watad, A., Amital, H., Langevitz, P., Bragazzi, N., Adawi, M., Pérez, D., Blank, M., Biln, N., Marotta, A., & Shoenfeld, Y. (n.d.). aB0287 Decrease in 14–3–3eta protein levels is correlated with improvement of clinical disease activity in tofacitinib treated early rheumatoid arthritis patients. Annals of the rheumatic diseases, 77, 1323. http://access.bl.uk/ark:/81055/vdc_100144721357.0x000048